CIK 0001820190 · <br>Emerging growth company
Scilex Holding Co
Sign in to watch- Ticker
- SCLX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 516-4310
- Business address
- 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
- Former names
- Scilex Holding Company/DE, Vickers Vantage Corp. I
Securities
- SCLX Common Stock Nasdaq
- SCLXW Warrant Nasdaq
- 4 Other disposition 10% owner disposed of 5,000,000 shares (other)
- 4 Open-market buy See Remarks bought 30,000 shares at $0.46 ($13,800)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Executive Chairperson bought 8,888 shares at $0.94 ($8,351)
- 4 Open-market buy See Remarks bought 32,000 shares at $0.99 ($31,670)
- 4 Open-market buy Director bought 1,000 shares at $0.99 ($990)
- 4 Open-market buy Director bought 5,000 shares at $0.95 ($4,750)
- 4 Open-market buy Director bought 20,000 shares at $0.95 ($18,992)
- 4 Open-market buy Director bought 2,000 shares at $0.90 ($1,800)
- 4 Open-market buy Executive Chairperson bought 10,000 shares at $0.97 ($9,710)
- 4 Open-market buy See Remarks bought 30,000 shares at $0.99 ($29,751)
- 4 Open-market buy Chief Financial Officer bought 6,700 shares at $0.97 ($6,499)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 1,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 5,000 shares (option exercise)
Page 2 of 5 · 93 filings